$TSOI Therapeutics Solutions in-licenses CTE/TBI c
Post# of 18238
Jul. 1, 2019 10:21 AM ET|About: Therapeutic Solutions ... (TSOI)|By: Douglas W. House, SA News Editor
Nano cap Therapeutic Solutions International (OTCPK:TSOI +53.3%) is up on almost double normal volume after securing exclusive rights to an adult stem cell called "JadiCell" for the potential treatment of chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI). CTE is the highly publicized injury affecting many football players.
The company says JadiCell is similar to mesenchymal stem cells but features enhanced growth factor production, a greater ability to secreted exosomes and superior angiogenic and neurogenic ability.